You are here

  • Home
  • Archive
  • Volume 73, Issue 3
  • Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial

Article metrics

Article menu
Download PDFPDF
Irritable bowel syndrome
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2024 to April 2025

AbstractFullPdf
Jan 20244539229144
Feb 202410729338171
Mar 20244224219132
Apr 2024405211393
May 202429507053
Jun 202420126451
Jul 202414635439
Aug 202413455244
Sep 202413935138
Oct 202417636042
Nov 202416223927
Dec 202413266425
Jan 202522465334
Feb 20254114433
Mar 20251295149
Apr 2025823526
Total4028615361001